Gainers: •$Veru Inc(VERU.US)$+11.4% (extends momentum from +13% move during regular session) •$Annovis Bio(ANVS.US)$+9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed) •$游戏驿站(GME.US)$+6.7% (announces 4-for-l stock split) •$Bed Bath & Beyond Inc(BBBY.US)$+6% (interim CEO purchases 50000 shares) •$瓦可能源(EGY.US)$+5.4% (completes South Tchibala 1HB-ST W...
Gainers: •$Kezar Life Sciences(KZR.US)$+92% (announces positive top line results from the MISSION Phase 2 trial) •$Sutro Biopharma(STRO.US)$+24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates) •$Ceragon(CRNT.US)$+17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh) •$携程网(TCOM.US)$+15.6% (In reaction to earnings/guidance) •$Apyx Medical(APYX.US)$+8% (anno...
阿维亚网络股票讨论区
2023前两季度营收增长13.9%,营业利润受营业费用大幅增长影响下滑1.6%,净利润下滑69%至330万。
目前市盈率19,市盈率TTM已经升至29,估值没有吸引力。
In reaction to earnings/guidance:
• $La-Z-Boy(LZB.US)$ +6.7%, $财捷(INTU.US)$ +5.8%, $Paycor HCM(PYCR.US)$ +3.3%, $II-VI Inc(IIVI.US)$ +3.3%, $戴康工业(DY.US)$ +2.2%
Other news:
• $Bed Bath & Beyond Inc(BBBY.US)$+35% (Bed Bath & Beyond shares are trading higher following reports suggesting the company secured a loan deal.)
• $Farfetch(FTCH.US)$ +18.2% (Farfetch, Richemont and Alabbar to partner in YOOX NET-A-PORTER)
...
• $Veru Inc(VERU.US)$ +11.4% (extends momentum from +13% move during regular session)
• $Annovis Bio(ANVS.US)$ +9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed)
• $游戏驿站(GME.US)$ +6.7% (announces 4-for-l stock split)
• $Bed Bath & Beyond Inc(BBBY.US)$ +6% (interim CEO purchases 50000 shares)
• $瓦可能源(EGY.US)$ +5.4% (completes South Tchibala 1HB-ST W...
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $携程网(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
暂无评论